Sebastian A. Brunemeier

Sebastian A. Brunemeier is a prominent figure in the field of longevity biotechnology and drug discovery, currently serving as the CEO & Founder of ImmuneAGE Bio since January 2022, which focuses on immune system rejuvenation. As the Founder of LongBio Institute, set to launch in August 2024, Sebastian aims to advance longevity biotech. Additionally, as a Co-founder & General Partner at Healthspan Capital, Sebastian leads a venture fund dedicated to longevity biotech and geroscience. Sebastian holds advisory roles in various organizations, including the Longevity Biotech Fellowship and Alpine Institute, and is a committee member for the Longevity Prize. With a diverse educational background that includes a PhD (ABD) in Biochemistry of Aging from the University of Oxford and multiple degrees in Biomedical Science, Business Management, and Human Biology, Sebastian has established a strong foundation for impactful contributions in the longevity sector.